Home > News > Where's the nano in this IPO?
May 23rd, 2004
Where's the nano in this IPO?
Hot, or perhaps lukewarm, on the heels of Nanosys comes what Reuters calls a “Nanotech IPO”, from Lumera. The claim to nanotech is controversial in two ways. Firstly, as nanotech penetrates more into industrial processes, does that suddenly make Lumera, Amgen, or IBM nanotech companies? Of course it doesn't.
Harris & Harris Group Continues Its Blog Series to Highlight Most Impactful Portfolio Companies With Champions Oncology, Inc. April 17th, 2014
Nanometrics to Announce First Quarter Financial Results on April 29, 2014 April 9th, 2014
Harris & Harris Group Notes Mersana's Collaboration Agreement With Subsidiary of Takeda Pharmaceutical Co. April 8th, 2014
Harris & Harris Group Continues Its Blog Series to Highlight Most Impactful Portfolio Companies With Metabolon, Inc. April 7th, 2014